FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jacek Niklinski

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Genes & Molecular Sequences

Genes, p53

Procedures

Immunoradiometric Assay

Physiology

Co-author Network

Publications

TOP 3
Regalla Kumarswamy; Giridhar Mudduluru; Santoshi Muppala; Jacek Niklinski; Mauro Papotti; Paolo Ceppi; Miroslaw Kozlowski; Heike Allgayer
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
Magdalena Groblewska; Miroslaw Kozlowski; Jerzy Laudanski; Barbara Mroczko; Jacek Niklinski; Maciej Szmitkowski
Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
Bozena Dobrzycka; Slawomir Terlikowski; Oksana Kowalczuk; Marek Kulikowski; Jacek Niklinski
Serum levels of VEGF and VEGF-C in patients with endometrial cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jacek Niklinski (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Regalla Kumarswamy; Giridhar Mudduluru; Santoshi Muppala; Jacek Niklinski; Mauro Papotti; Paolo Ceppi; Miroslaw Kozlowski; Heike Allgayer
MicroRNA-30a inhibits epithelial-to-mesenchymal transition by targeting Snai1 and is downregulated in non-small cell lung cancer.
International journal of cancer. Journal international du cancer 2012;130(9):2044-53.
2012: Magdalena Groblewska; Miroslaw Kozlowski; Jerzy Laudanski; Barbara Mroczko; Jacek Niklinski; Maciej Szmitkowski
Serum matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases 2 in esophageal cancer patients.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2012;50(4):590-8.
2011: Bozena Dobrzycka; Slawomir Terlikowski; Oksana Kowalczuk; Marek Kulikowski; Jacek Niklinski
Serum levels of VEGF and VEGF-C in patients with endometrial cancer.
European cytokine network 2011;22(1):45-51.
2011: Bozena Dobrzycka; Magdalena Garbowicz; Jacek Niklinski; Slawomir Terlikowski; Lech Chyczewski; Marek Kulikowski
The prognostic significance of the immunohistochemical expression of P53 and BCL-2 in endometrial cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2011;49(4):631-5.
2010: Bozena Dobrzycka; Slawomir Terlikowski; Piotr Szymon Bernaczyk; Magdalena Garbowicz; Jacek Niklinski; Lech Chyczewski; Marek Kulikowski
Prognostic significance of smac/DIABLO in endometrioid endometrial cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2010;48(4):678-81.
2010: Miroslaw Kozlowski; Oksana Kowalczuk; Robert Milewski; Lech Chyczewski; Jacek Niklinski; Jerzy Laudański
Serum vascular endothelial growth factors C and D in patients with oesophageal cancer.
European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2010;38(3):260-7.
2009: Wojciech Jelski; Miroslaw Kozlowski; Jerzy Laudanski; Jacek Niklinski; Maciej Szmitkowski
Alcohol dehydrogenase isoenzymes and aldehyde dehydrogenase activity in the sera of patients with esophageal cancer.
Clinical and experimental medicine 2009;9(2):131-7.
2009: Wojciech Jelski; Miroslaw Kozlowski; Jerzy Laudanski; Jacek Niklinski; Maciej Szmitkowski
The activity of class I, II, III, and IV alcohol dehydrogenase (ADH) isoenzymes and aldehyde dehydrogenase (ALDH) in esophageal cancer.
Digestive diseases and sciences 2009;54(4):725-30.
2009: Paul Roepman; Jacek Jassem; Egbert F Smit; Thomas Muley; Jacek Niklinski; Tony van de Velde; Anke T Witteveen; Witold Rzyman; Arno Floore; Sjaak Burgers; Giuseppe Giaccone; Michael Meister; Hendrik Dienemann; Marcin Skrzypski; Miroslaw Kozlowski; Wolter J Mooi; nico van zandwijk
An immune response enriched 72-gene prognostic profile for early-stage non-small-cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(1):284-90.
2008: Mariëlle I Gallegos-Ruiz; Karijn Floor; Paul Roepman; José A Rodriguez; Gerrit A Meijer; Wolter J Mooi; Ewa Jassem; Jacek Niklinski; Thomas Muley; nico van zandwijk; Egbert F Smit; Kristin Beebe; Len Neckers; Bauke Ylstra; Giuseppe Giaccone
Integration of gene dosage and gene expression in non-small cell lung cancer, identification of HSP90 as potential target.
PloS one 2008;3(3):e0001722.
2008: Walentyn Pankiewicz; Anetta Sulewska; Wieslawa Niklinska; Wojciech Naumnik; Jerzy Laudanski; Jacek Niklinski; Lech Chyczewski
Immunoexpression of P16INK4a, Rb and TP53 proteins in bronchiolar columnar cell dysplasia (BCCD) in lungs resected due to primary non-small cell lung cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2008;46(1):89-96.
2007: Anetta Sulewska; Wieslawa Niklinska; Miroslaw Kozlowski; Łukasz Minarowski; Wojciech Naumnik; Jacek Niklinski; Katarzyna Dabrowska; Lech Chyczewski
Detection of DNA methylation in eucaryotic cells.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2007;45(4):315-24.
2007: Miroslaw Kozlowski; Oksana Kowalczuk; Anetta Sulewska; Piotr Dziegielewski; Grzegorz Lapuc; Wojciech Laudanski; Wieslawa Niklinska; Lech Chyczewski; Jacek Niklinski; Jerzy Laudanski
Serum soluble Fas ligand (sFasL) in patients with primary squamous cell carcinoma of the esophagus.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2007;45(3):199-204.
2007: Anetta Sulewska; Wieslawa Niklinska; Miroslaw Kozlowski; Łukasz Minarowski; Wojciech Naumnik; Jacek Niklinski; Katarzyna Dabrowska; Lech Chyczewski
DNA methylation in states of cell physiology and pathology.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2007;45(3):149-58.
2004: Jacek Niklinski; Wieslawa Niklinska; Elzbieta Chyczewska; Jerzy Laudanski; Wojciech Naumnik; Lech Chyczewski; Eric Pluygers
The epidemiology of asbestos-related diseases.
Lung cancer (Amsterdam, Netherlands) 2004;45 Suppl 1():S7-S15.
2004: Adam Szpechcinski; R Trzos; Piotr Jarocki; Ladislas A Trojan; K Oficjalska; A Junkiert; Ming X Wei; M Mazurek; Joanna Czapiewska; Jacek Niklinski; P Kopiński; L Chyczewski; I Kasacka; Jerzy Trojan
Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.
Roczniki Akademii Medycznej w Białymstoku (1995) 2004;49 Suppl 1():98-104.
2002: Fred R Hirsch; Jürgen R Fischer; Jacek Niklinski; Sabine Zöchbaüer-Müller
Future developments in the treatment of lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 3():S81-5.
2002: Jacek Niklinski; Fred R Hirsch
Molecular approaches to lung cancer evaluation.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 3():S9-17.
2002: Jacek Niklinski; Jerzy Laudanski; Lech Chyczewski; J Jassem; JR Fischer; Ch Manegold
International conference on 'Non Small Cell Lung Cancer: Standards and New Trends in Diagnosis and Therapy', October 5-7, 2001, medical academy of Bialystok, Bialystok, Poland.
Lung cancer (Amsterdam, Netherlands) 2002;37(1):109-12.
2002: JR Fischer; P Baas; H D Becker; Lech Chyczewski; Hendrik Dienemann; Peter Drings; Werner Ebert; Felix Herth; H Hoffmann; Jerzy Laudanski; Harald Lahm; Ch Manegold; Mariano Monzó; W J Mooi; Thomas Muley; A Neuner; Jacek Niklinski; Wieslawa Niklinska; Rafael Rosell; Miquel Taron; L van't Veer; Bernd Werle; N v Zandwijk
Report from the first meeting of the 'European Network on Translational Research in Lung Cancer Amsterdam-Barcelona-Bialystok-Heidelberg'. Thoraxklinik Heidelberg, Germany, July 25, 2001.
Lung cancer (Amsterdam, Netherlands) 2002;36(2):221-4.
2001: Lech Chyczewski; Jacek Niklinski; Elzbieta Chyczewska; Wieslawa Niklinska; Wojciech Naumnik
Morphological aspects of carcinogenesis in the lung.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S17-25.
2001: Jacek Niklinski; Wieslawa Niklinska; Lech Chyczewski; H D Becker; Eric Pluygers
Molecular genetic abnormalities in premalignant lung lesions: biological and clinical implications.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2001;10(3):213-26.
2001: Barbara Mroczko; Maciej Szmitkowski; Jacek Niklinski
Granulocyte-Colony stimulating factor and macrophage-colony stimulating factor in patients with non-small-cell lung cancer.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(5):374-9.
2001: Jerzy Laudanski; Wieslawa Niklinska; T Burzykowski; Lech Chyczewski; Jacek Niklinski
Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer.
The European respiratory journal 2001;17(4):660-6.
2001: Oksana Kovalchuk; Wojciech Naumnik; A Serwicka; Elzbieta Chyczewska; Jacek Niklinski; Lech Chyczewski
K-ras codon 12 mutations may be detected in serum of patients suffering from adeno- and large cell lung carcinoma. A preliminary report.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39 Suppl 2():70-2.
2001: Oksana Kovalchuk; Elzbieta Chyczewska; Wieslawa Niklinska; Jacek Niklinski; Wojciech Naumnik; Lech Chyczewski
K-ras codon 12 mutations detected with enriched PCR method in operable non-small cell lung cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39 Suppl 2():68-9.
2001: Wieslawa Niklinska; Lech Chyczewski; Jerzy Laudanski; Elzbieta Chyczewska; Jacek Niklinski
Detection of p16 abnormalities in early-stage non-small cell lung cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39 Suppl 2():30-2.
2001: Wieslawa Niklinska; Jerzy Laudanski; Jacek Niklinski
G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview.
Neoplasma 2001;48(3):157-63.
2001: Wieslawa Niklinska; Lech Chyczewski; Jacek Niklinski
New molecular approaches to lung cancer: biological and clinical implications of P53, P16 and K-RAS studies.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):99-103.
2001: Wieslawa Niklinska; T Burzykowski; Jerzy Laudanski; Elzbieta Chyczewska; Lech Chyczewski; Jacek Niklinski
Strong association between P53 protein accumulation, serum antibodies and gene mutation in non-small cell lung cancer.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):51-6.
2001: Wieslawa Niklinska; Lech Chyczewski; Jerzy Laudanski; Boguslaw Sawicki; Jacek Niklinski
Detection of P53 abnormalities in non-small cell lung cancer by yeast functional assay.
Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society 2001;39(2):147-8.
2000: Wieslawa Niklinska; T Burzykowski; Lech Chyczewski; M R Rusin; M Furman; Jerzy Laudanski; Elzbieta Chyczewska; M Sulik; Jacek Niklinski
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2000;9(2):81-7.
1999: Barbara Mroczko; Maciej Szmitkowski; Jacek Niklinski
Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(10):959-62.
1998: Jerzy Laudanski; T Burzykowski; Wieslawa Niklinska; K Chyczewski; M Furman; Jacek Niklinski
Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1998;22(3):191-200.
1998: Jacek Niklinski; T Burzykowski; Wieslawa Niklinska; Jerzy Laudanski; Lech Chyczewski; M Rapellino; M Furman
Preoperative CYFRA 21-1 level as a prognostic indicator in resected nonsmall cell lung cancer.
The European respiratory journal 1998;12(6):1424-8.
1996: Jacek Niklinski; M Furman; T Burzykowski; Lech Chyczewski; Jerzy Laudanski; Elzbieta Chyczewska; M Rapellino
Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer.
British journal of cancer 1996;74(6):956-60.
1995: Jacek Niklinski; M Furman; M Rapellino; Lech Chyczewski; Jerzy Laudanski; A Oliaro; Enrico Ruffini
CYFRA 21-1 determination in patients with non-small cell lung cancer: clinical utility for the detection of recurrences.
The Journal of cardiovascular surgery 1995;36(5):501-4.
1995: Jacek Niklinski; M Furman
Clinical tumour markers in lung cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1995;4(2):129-38.
1995: M Rapellino; Jacek Niklinski; F Pecchio; M Furman; Simona Baldi; L Chyczewski; Enrico Ruffini; Elzbieta Chyczewska
CYFRA 21-1 as a tumour marker for bronchogenic carcinoma.
The European respiratory journal 1995;8(3):407-10.
1995: Jacek Niklinski; M Furman; Elzbieta Chyczewska; Lech Chyczewski; Franciszek Rogowski; Jerzy Laudanski
Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer.
The European respiratory journal 1995;8(2):291-4.
1994: Jacek Niklinski; M Furman; Elzbieta Chyczewska; Lech Chyczewski; Franciszek Rogowski; E Jaroszewicz; Jerzy Laudanski
Evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1994;3(2):227-30.
1992: Jacek Niklinski; M Furman; Jerzy Laudanski; M Kozlowski
Prognostic value of pretreatment CEA, SCC-Ag and CA 19-9 levels in sera of patients with non-small cell lung cancer.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 1992;1(6):401-6.